Detalhe da pesquisa
1.
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice.
Mov Disord
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576081
2.
Genetic Testing in Clinical Movement Disorders: A Case-Based Review.
Semin Neurol
; 43(1): 147-155, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854393
3.
Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis.
Neurol Sci
; 44(3): 947-959, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441344
4.
The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates.
J Biol Chem
; 296: 100050, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168630
5.
Animal models of α-synucleinopathy for Parkinson disease drug development.
Nat Rev Neurosci
; 18(9): 515-529, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747776
6.
Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study.
Mov Disord
; 37(10): 2134-2139, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089809
7.
Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.
Mov Disord
; 36(8): 1772-1780, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963552
8.
Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease.
Pharmacoepidemiol Drug Saf
; 30(2): 201-209, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219601
9.
Botulinum Toxin-Associated Prolonged Remission of Idiopathic Cervical Dystonia.
Can J Neurol Sci
; 48(6): 864-868, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397526
10.
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.
Crit Rev Clin Lab Sci
; 57(5): 291-307, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32116096
11.
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.
Pharmacoepidemiol Drug Saf
; 29(8): 864-872, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410265
12.
Parkinsonism due to A53E α-synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features.
Mov Disord
; 33(12): 1950-1955, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423204
13.
α-Synuclein and Parkinsonism: Updates and Future Perspectives.
Curr Neurol Neurosci Rep
; 17(4): 31, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324300
14.
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.
Proc Natl Acad Sci U S A
; 111(7): 2626-31, 2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510904
15.
Parkinson's disease.
Lancet
; 386(9996): 896-912, 2015 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25904081
16.
α-Synuclein and Lewy pathology in Parkinson's disease.
Curr Opin Neurol
; 28(4): 375-81, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26110807
17.
Disease-modifying strategies for Parkinson's disease.
Mov Disord
; 30(11): 1442-50, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26208210
18.
α-Synuclein oligomers and clinical implications for Parkinson disease.
Ann Neurol
; 73(2): 155-69, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225525
19.
Neuroscience fundamentals relevant to neuromodulation: Neurobiology of deep brain stimulation in Parkinson's disease.
Neurotherapeutics
; 21(3): e00348, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579455
20.
If Art Were a Drug: Implications for Parkinson's Disease.
J Parkinsons Dis
; 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788090